欧盟法规
C&L通报上下游产品
CAS号89324-44-7 5-甲酰基噻吩-3-羧酸 | CAS号74-88-4 碘甲烷合成工艺路线路线简述
- 合成目标产物 Methyl 2-Formyl-4-Thiophenecarboxylate 主要起始原料 4-Bromothiophene-2-Carboxaldehyde Ethylene Glycol Acetal
- (文献来源)合成步骤主要原料 4-Bromothiophene-2-Carboxaldehyde Ethylene Glycol Acetal
📜4-溴噻吩-2-甲醛乙二醇缩醛置于盐酸,叔丁基锂体系中,用 四氢呋喃,乙醚,正己烷,水 作为反应溶剂,化学反应 5.25H,反应生成 2-醛基噻吩-4-甲酸甲酯
参考文献: Tricyclic Imidazole Compounds As Inhibitors Of Tryptophan Hydroxylase[fr] Composés Imidazole Tricycliques Comme Inhibiteurs De La Tryptophane Hydrolase
标题: Tricyclic Imidazole Compounds As Inhibitors Of Tryptophan Hydroxylase[fr] Composés Imidazole Tricycliques Comme Inhibiteurs De La Tryptophane Hydrolase
摘要:本发明涉及式(I)的化合物,其中r1A,R1B,R2,R3和x如描述中所述,其制备方法,其药用盐,以及作为药物的用途,含有一个或多个式(I)化合物的药物组合物,制备这种式(I)化合物的方法,特别是它们作为tph调节剂的用途.
专利信息
专利号:US-11286268-B1
优先权日:2019-07-02
标题:EIF4E-inhibiting compounds and methods
发明人:SPERRY SAMUEL; XIANG ALAN X; ERNST JUSTIN T; REICH SIEGFRIED H; SPRENGELER PAUL A; SHAGHAFI MIKE; MICHELS THEO; NILEWSKI CHRISTIAN; TRAN CHINH VIET; PACKARD Garrick Kenneth; GRUBBS ALAN; URKALAN KAVERI; MUKAIYAMA TAKASUKE
权利人:EFFECTOR THERAPEUTICS INC
摘要:The present invention provides synthesis, pharmaceutically acceptable formulations and uses of compounds in accordance with Formula I, or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof. n n n n n n n n n n For Formula I compounds X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , Q, L 1 , L 2 , Y, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and rings A, B and C are as defined in the specification. The inventive Formula I compounds are inhibitors of eIF4e and find utility in any number of therapeutic applications, including but not limited to treatment of inflammation and various cancers.
专利号:RO-106402-B1
优先权日:1989-04-18
标 题:DERIVATIVES OF 2-OXINDOL-3-SUBSTITUTES, THE PROCESS OF OBTAINING AND INTERMEDIARIES IN THEIR SYNTHESIS